11-07 Sapporo Clinical Laboratory Inc - to retire treasury shares worth 26% of outstanding stock on February 17 RE
27/03/24 Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 26, 2024. CI
26/03/24 Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on March 26, 2024, has closed with 210,800 shares, representing 6.33% for ¥189.93 million. CI
26/02/24 Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 232,100 shares, representing 6.97% for ¥209.12 million. CI
26/02/24 Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan. CI
12/05/23 Sapporo Clinical Laboratory Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
31/05/22 Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on May 30, 2022. CI
31/05/22 Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on May 30, 2022 has closed with 22,700 shares, representing 0.67% for ¥29.21 million. CI
30/05/22 Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 22,700 shares, representing 0.68% for ¥29.21 million. CI
30/05/22 Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan. CI
01/03/22 Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 28, 2022. CI
01/03/22 Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on February 28, 2022, has closed with 53,700 shares, representing 1.58% for ¥69.11 million. CI
28/02/22 Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 53,700 shares, representing 1.58% for ¥69.11 million. CI
Manager TitleAgeSince
President 54 29/06/2022
Sales & Marketing 63 01/04/2003
Corporate Officer/Principal 62 01/03/2013
Director TitleAgeSince
Chairman 87 01/06/2001
Director/Board Member 54 01/06/2001
Director/Board Member 68 01/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-0.41%-0.41% - - 38.32M
-0.99%-6.37%-15.74%+89.66% 1.94B
+1.50%-0.11%-17.88%+31.29% 1.32B
-0.60%-14.51%-5.08%-3.60% 1.08B
+0.52%-1.16%+9.27%+24.76% 1.09B
-0.91%-0.25%+49.27%+112.13% 351M
+1.19%+0.89%-38.29% - 306M
+5.04%+2.32%-16.43%+30.19% 242M
+0.47%+0.37%-20.40%+12.61% 210M
+3.20%-3.82%-3.73%+60.12% 116M
Average +0.88%-2.95%-6.56%+44.64% 740.14M
Weighted average by Cap. +0.22%-4.58%-7.93%+46.39%
Logo Sapporo Clinical Laboratory Inc.
SAPPORO CLINICAL LABORATORY INC. is a Japan-based company mainly engaged in the dispensing pharmacy business. The Company operates in three business segments. The Clinical Examination segment is engaged in the provision of clinical examination needed in medical examinations in hospitals. The Dispensing Pharmacy segment is engaged in operation of dispensing pharmacies, as well as wholesale of drugs and medicines. The Medical Equipment Sale and Maintenance segment is engaged in the sale and maintenance of high level medical equipment, general medical equipment, as well as physics and chemistry equipment. The others business is engaged in the development, sale and maintenance of software for clinical examination system.
Employees
879
  1. Stock Market
  2. Stocks
  3. 9776 Stock